Brief: Percheron Therapeutics Posts FY Loss Attributable Of A$11.9 Mln
Aug 29 (Reuters) - Percheron Therapeutics Ltd PER.AX :
* FY LOSS ATTRIBUTABLE A$11.9 MILLION
* FY REVENUE & OTHER INCOME A$3 MILLION
Further company coverage: PER.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Percheron Therapeutics
See all newsBrief: Invion Announces Preclinical Research Collaboration With Percheron Therapeutics
Brief: Percheron Therapeutics Receives Firm Commitments For A$2.3 Million Institutional Placement
Brief: Percheron Therapeutics Appoints Ambrosini as Interim Board Member During CEO Transition Period
Brief: Percheron Therapeutics Says Vanderbilt Health To Conduct Clinical Trial Of Hmbd-002 In Acute Myeloid Leukaemia
Brief: Percheron Therapeutics Says James Garner To Step Down As CEO And Managing Director